New Stanford and UPenn study found up to 66% of patient comorbidities missed at the initial patient admission stage. Why? How ...

New non-opioid pain killer get FDA approval for acute pain. Patients are taking note. Also demonstrated efficacy, just not enough over Hydrocodone + Acetaminophen. But….there’s more. What about ...